Let's be honest. When you hear about a company actively working to bring back extinct animals using genetic science, your mind probably jumps to one place: Jurassic Park. The iconic gates, the majestic (and terrifying) dinosaurs, and the tagline that promised a walk with prehistory are permanently etched in our cultural DNA. And yes, on the surface, the celebrity loved Colossal Biosciences, with its sights set on the Woolly Mammoth, Tasmanian Tiger, and Dodo, shares that initial, breathtaking "wow" factor. As they did with the announcements of their Woolly Mouse and Dire Wolf, which dominated global headlines. They are, in essence, making the impossible possible, leveraging incredible scientific advancements to resurrect creatures lost to time. That shared ambition, the audacious reach into the past, is where the most compelling comparison begins and ends.
While the premise might sound like a Spielberg pitch, the reality of Colossal Biosciences is entirely different. The crucial divergence lies in the "why." InGen built a theme park for profit and spectacle, with a famously cavalier attitude towards consequences. Colossal, however, frames its mission firmly within conservation and ecosystem restoration. Their goal isn't petting zoos filled with mammoths but reintroducing functionally equivalent animals to help repair damaged environments, like the Arctic tundra.
